scholarly journals Light-at-night, circadian disruption and breast cancer: assessment of existing evidence

2009 ◽  
Vol 38 (4) ◽  
pp. 963-970 ◽  
Author(s):  
R. G Stevens
Author(s):  
Abed E. Zubidat ◽  
Abraham Haim

AbstractBoth obesity and breast cancer are already recognized worldwide as the most common syndromes in our modern society. Currently, there is accumulating evidence from epidemiological and experimental studies suggesting that these syndromes are closely associated with circadian disruption. It has been suggested that melatonin (MLT) and the circadian clock genes both play an important role in the development of these syndromes. However, we still poorly understand the molecular mechanism underlying the association between circadian disruption and the modern health syndromes. One promising candidate is epigenetic modifications of various genes, including clock genes, circadian-related genes, oncogenes, and metabolic genes. DNA methylation is the most prominent epigenetic signaling tool for gene expression regulation induced by environmental exposures, such as artificial light-at-night (ALAN). In this review, we first provide an overview on the molecular feedback loops that generate the circadian regulation and how circadian disruption by ALAN can impose adverse impacts on public health, particularly metabolic disorders and breast cancer development. We then focus on the relation between ALAN-induced circadian disruption and both global DNA methylation and specific loci methylation in relation to obesity and breast cancer morbidities. DNA hypo-methylation and DNA hyper-methylation, are suggested as the most studied epigenetic tools for the activation and silencing of genes that regulate metabolic and monostatic responses. Finally, we discuss the potential clinical and therapeutic roles of MLT suppression and DNA methylation patterns as novel biomarkers for the early detection of metabolic disorders and breast cancer development.


Healthcare ◽  
2021 ◽  
Vol 9 (6) ◽  
pp. 649
Author(s):  
Javier Fagundo-Rivera ◽  
Regina Allande-Cussó ◽  
Mónica Ortega-Moreno ◽  
Juan Jesús García-Iglesias ◽  
Adolfo Romero ◽  
...  

Shift work that involves circadian disruption has been highlighted as a likely carcinogenic factor for breast cancer in humans. Also, unhealthy lifestyle habits observed in night work nurses could be causally related to an increase in the incidence of estrogen-positive breast tumours in this population. Assessing baseline risk of breast cancer in nurses is essential. The objective of this study was to analyze the risk of breast cancer that nurses had in relation to their lifestyle and labour factors related to shift work. A cross-sectional descriptive study through a questionnaire about sociodemographic variables, self-perception of health, and working life was designed. The sample consisted of 966 nurses. The relationship between variables was tested. A binary logistic regression and a classification and regression tree were performed. The most significant labour variables in relation to the risk of breast cancer were the number of years worked (more than 16 years; p < 0.01; OR = 8.733, 95% CI = 2.811, 27.134) and the total years performing more than 3 nights per month (10 or more years; p < 0.05; OR = 2.294, 95% CI = 1.008, 5.220). Also, the nights worked throughout life (over 500; OR = 4.190, 95% CI = 2.118, 8.287) were significant in the analysis. Nurses who had or ever had breast cancer valued their self-perceived health more negatively (p < 0.001) and referred a lower quality of sleep (p < 0.001) than the non-cases nurses. The occupational factors derived from night work could have several impacts on nurses’ health and their family-work balance. Promoting healthy lifestyles, informing about shift work risks, and adjusting shift work schedules are critical methods to decrease the possible effects of circadian disruption in nurses.


2013 ◽  
Vol 64 (3) ◽  
pp. 207-218 ◽  
Author(s):  
Richard G. Stevens ◽  
George C. Brainard ◽  
David E. Blask ◽  
Steven W. Lockley ◽  
Mario E. Motta

2018 ◽  
Vol 25 (1) ◽  
pp. 107327481881290 ◽  
Author(s):  
A. E. Zubidat ◽  
B. Fares ◽  
F. Fares ◽  
A. Haim

Lighting technology is rapidly advancing toward shorter wavelength illuminations that offer energy-efficient properties. Along with this advantage, the increased use of such illuminations also poses some health challenges, particularly breast cancer progression. Here, we evaluated the effects of artificial light at night (ALAN) of 4 different spectral compositions (500-595 nm) at 350 Lux on melatonin suppression by measuring its urine metabolite 6-sulfatoxymelatonin, global DNA methylation, tumor growth, metastases formation, and urinary corticosterone levels in 4T1 breast cancer cell-inoculated female BALB/c mice. The results revealed an inverse dose-dependent relationship between wavelength and melatonin suppression. Short wavelength increased tumor growth, promoted lung metastases formation, and advanced DNA hypomethylation, while long wavelength lessened these effects. Melatonin treatment counteracted these effects and resulted in reduced cancer burden. The wavelength suppression threshold for melatonin-induced tumor growth was 500 nm. These results suggest that short wavelength increases cancer burden by inducing aberrant DNA methylation mediated by the suppression of melatonin. Additionally, melatonin suppression and global DNA methylation are suggested as promising biomarkers for early diagnosis and therapy of breast cancer. Finally, ALAN may manifest other physiological responses such as stress responses that may challenge the survival fitness of the animal under natural environments.


2020 ◽  
Author(s):  
Davide M. Dominoni ◽  
Maaike de Jong ◽  
Kees van Oers ◽  
Peter O’Shaughnessy ◽  
Gavin Blackburn ◽  
...  

AbstractGlobally increasing levels of artificial light at night (ALAN) have been associated with shifts in behavioral rhythms of many wild organisms. It is however unknown to what extent this change in behavior is due to shifts in the circadian clock, and, importantly, whether the physiological pathways orchestrated by the circadian clock are desynchronized by ALAN. Such circadian disruption could have severe consequences for wildlife health, as shown for humans. Here, we analyze the effects of experimental ALAN on rhythmic behavior, gene expression and metabolomic profiles in a wild songbird, the great tit (Parus major). We exposed 34 captive males to three ALAN intensities or to dark nights and recorded their activity rhythms. After three weeks, we collected mid-day and midnight samples of hypothalamus, hippocampus, liver, spleen and plasma. ALAN advanced wake-up time, and this shift was paralleled by an advance in hypothalamic expression of the clock gene BMAL1, which is key to integrating physiological pathways. BMAL1 advances were remarkably consistent across tissues, suggesting close links of brain and peripheral clock gene expression with activity rhythms. However, only a minority of other candidate genes (4 out of 12) paralleled the shifted BMAL1 expression. Moreover, metabolomic profiling showed that only 9.7% of the 755 analyzed metabolites followed the circadian shift. Thus, despite the shifted timing of key clock functions under ALAN, birds suffered internal desynchronization. We thus suggest circadian disruption to be a key link between ALAN and health impacts, in birds and humans alike.Significance StatementShifts in daily activity are a common consequence of artificial light at night (ALAN). In humans, shifted activity cycles often become desynchronized from internal physiological rhythms, with serious health implications. To what extent a similar desynchronization occurs in wild animals experiencing ALAN is currently unknown. We exposed captive great tits to increasing levels of LAN, and found that activity patterns and a core clock gene, BMAL1, shifted in concert. However, only a minority of additional candidate genes and less than 10% of the metabolites followed this circadian shift, suggesting internal desynchronization of physiological rhythms. Our study emphasizes the massive potential for ALAN to impact the health of wild animals through circadian disruption.


2006 ◽  
Vol 164 (4) ◽  
pp. 358-366 ◽  
Author(s):  
Erin S. O'Leary ◽  
Elinor R. Schoenfeld ◽  
Richard G. Stevens ◽  
Geoffrey C. Kabat ◽  
Kevin Henderson ◽  
...  

2012 ◽  
Vol 26 (11) ◽  
pp. 1808-1820 ◽  
Author(s):  
Lulu Mao ◽  
Robert T. Dauchy ◽  
David E. Blask ◽  
Lauren M. Slakey ◽  
Shulin Xiang ◽  
...  

Abstract Disturbed sleep-wake cycle and circadian rhythmicity are associated with cancer, but the underlying mechanisms are unknown. Employing a tissue-isolated human breast xenograft tumor nude rat model, we observed that glycogen synthase kinase 3β (GSK3β), an enzyme critical in metabolism and cell proliferation/survival, exhibits a circadian rhythm of phosphorylation in human breast tumors. Exposure to light-at-night suppresses the nocturnal pineal melatonin synthesis, disrupting the circadian rhythm of GSK3β phosphorylation. Melatonin activates GSK3β by inhibiting the serine-threonine kinase Akt phosphorylation, inducing β-catenin degradation and inhibiting epithelial-to-mesenchymal transition, a fundamental process underlying cancer metastasis. Thus, chronic circadian disruption by light-at-night via occupational exposure or age-related sleep disturbances may contribute to cancer incidence and the metastatic spread of breast cancer by inhibiting GSK3β activity and driving epithelial-to-mesenchymal transition in breast cancer patients.


Sign in / Sign up

Export Citation Format

Share Document